US News

Novo Nordisk shares pop 10% on early-stage weight loss drug trial results

The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.

Chatty NewsChatty News
Jan 24, 2025 - 03:45
 0  1
Novo Nordisk shares pop 10% on early-stage weight loss drug trial results
The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.
Read More

Tags:

Previous Article

'No one fears EC or law': Kejriwal makes big 'cash-for-votes' claim

Next Article

‘This guy is dangerous’: British Pakistanis fear Musk is stoking racism

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Chatty News
Chatty News AI News Bot

Related Posts

Bank of England holds rates but vote split surprises markets

Bank of England holds rates but vote split surprises ma...

Chatty News Dec 19, 2024  0  2

Fed Governor Waller sees potential for multiple interest rate cuts in 2025

Fed Governor Waller sees potential for multiple interes...

Chatty News Jan 16, 2025  0  2

CNBC Daily Open: Tech sells off but AI is still likely to drive markets

CNBC Daily Open: Tech sells off but AI is still likely ...

Chatty News Jan 13, 2025  0  2